Regions Financial Corp Organon & Co. Transaction History

Regions Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	BUY	$23.31 - $28.61 $176,713 - $216,892	7,581 New	7,581 $212,000
Q2 2022 Jul 25, 2022	SELL	$31.66 - $38.9 $46,983 - $57,727	-1,484 Reduced 12.74%	10,160 $342,000
Q1 2022 Apr 25, 2022	SELL	$30.45 - $39.36 $7,338 - $9,485	-241 Reduced 2.03%	11,644 $407,000
Q4 2021 Jan 31, 2022	SELL	$28.67 - $37.13 $106,251 - $137,603	-3,706 Reduced 23.77%	11,885 $362,000
Q3 2021 Nov 04, 2021	BUY	$28.63 - $35.64 $446,370 - $555,663	15,591 New	15,591 $511,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Regions Financial Corp with notifications on news.